Adiponectin deficiency modulates adhesion molecules expression and cytokine production but does not affect disease severity in the transfer model of colitis

Cytokine

Volumn 47, Issue 2, 2009, Pages 119-125

  Gove, Melissa E ^a   Pini, Maria ^a   Fayad, Raja ^a,c   Cabay, Robert J ^b   Fantuzzi, Giamila ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Colon; Inflammation; Inflammatory bowel disease

Indexed keywords

ADIPONECTIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; LEPTIN; RAG1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; DISEASE SEVERITY; GENE EXPRESSION REGULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADIPONECTIN; ANIMALS; ANTIGENS, CD45; CELL ADHESION MOLECULES; COLITIS; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; LEPTIN; LEUKOCYTES; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

MUS;

EID: 67650621583     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.05.010     Document Type: Article

References (34)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 (2005) 911-919 quiz 920
2. Goldstein B.J., and Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 (2004) 2563-2568
3. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
4. Arita Y., Kihara S., Ouchi N., Maeda K., Kuriyama H., Okamoto Y., et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 (2002) 2893-2898
5. Wolf A.M., Wolf D., Rumpold H., Enrich B., and Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323 (2004) 630-635
6. Wulster-Radcliffe M.C., Ajuwon K.M., Wang J., Christian J.A., and Spurlock M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316 (2004) 924-929
7. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121 (2008) 326-330
8. Sada K.E., Yamasaki Y., Maruyama M., Sugiyama H., Yamamura M., Maeshima Y., et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33 (2006) 1545-1552
9. Senolt L., Pavelka K., Housa D., and Haluzik M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 35 (2006) 247-252
10. Otero M., Lago R., Gomez R., Lago F., Dieguez C., Gomez-Reino J.J., et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65 (2006) 1198-1201
11. Rovin B.H., Song H., Hebert L.A., Nadasdy T., Nadasdy G., Birmingham D.J., et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int 68 (2005) 1825-1833
12. Perseghin G., Lattuada G., Danna M., Sereni L.P., Maffi P., De Cobelli F., et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285 (2003) E1174-E1181
13. Karmiris K., Koutroubakis I.E., Xidakis C., Polychronaki M., Voudouri T., and Kouroumalis E.A. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 100-105
14. Yamamoto K., Kiyohara T., Murayama Y., Kihara S., Okamoto Y., Funahashi T., et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 54 (2005) 789-796
15. Paul G., Schaffler A., Neumeier M., Furst A., Bataillle F., Buechler C., et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 12 (2006) 471-477
16. Fayad R., Pini M., Sennello J.A., Cabay R.J., Chan L., Xu A., et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 132 (2007) 601-614
17. Nishihara T., Matsuda M., Araki H., Oshima K., Kihara S., Funahashi T., et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131 (2006) 853-861
18. Pini M, Gove ME, Fayad R, Cabay RJ, Fantuzzi G. Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 KO mice. Am J Physiol Gastrointest Liver Physiol 2008;113:G382-7.
19. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., and Coffman R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1 (1994) 553-562
20. Izcue A., Coombes J.L., and Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212 (2006) 256-271
21. Ostanin DV, Boa R, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M et al. T-cell transfer model of chronic colitis: concepts, considerations and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2008;296:G135-46.
22. Takeuchi T., Adachi Y., Ohtsuki Y., and Furihata M. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 40 (2007) 115-120
23. Park P.H., McMullen M.R., Huang H., Thakur V., and Nagy L.E. Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-alpha) expression via ERK1/2 activation and Egr-1 expression: role of TNF-alpha in adiponectin-stimulated interleukin-10 production. J Biol Chem 282 (2007) 21695-21703
24. Alberti L., Gilardini L., Girola A., Moro M., Cavagnini F., and Invitti C. Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. Diabetes Obes Metab 9 (2007) 344-349
25. Ouedraogo R., Gong Y., Berzins B., Wu X., Mahadev K., Hough K., et al. Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 117 (2007) 1718-1726
26. Rivera-Nieves J., Gorfu G., and Ley K. Leukocyte adhesion molecules in animal models of inflammatory bowel disease. Inflamm Bowel Dis 14 (2008) 1715-1735
27. Elson C.O., Cong Y., McCracken V.J., Dimmitt R.A., Lorenz R.G., and Weaver C.T. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206 (2005) 260-276
28. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
29. Rovin B.H., and Song H. Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin Immunol 120 (2006) 99-105
30. Okamoto Y., Folco E.J., Minami M., Wara A.K., Feinberg M.W., Sukhova G.K., et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res 102 (2008) 218-225
31. Sanchez-Munoz F., Dominguez-Lopez A., and Yamamoto-Furusho J.K. Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14 (2008) 4280-4288
32. Mueller C. Tumour necrosis factor in mouse models of chronic intestinal inflammation. Immunology 105 (2002) 1-8
33. Karmiris K., Koutroubakis I.E., and Kouroumalis E.A. Leptin, adiponectin, resistin, and ghrelin-implications for inflammatory bowel disease. Mol Nutr Food Res 52 (2008) 855-866
34. Karagiannides I., Kokkotou E., Tansky M., Tchkonia T., Giorgadze N., O'Brien M., et al. Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc Natl Acad Sci USA 103 (2006) 5207-5212